| Cheryl Patterson, MD | |
|
36475 5 Mile Rd, Livonia, MI 48154-1971 | |
| (734) 655-2022 | |
| Not Available |
| Full Name | Cheryl Patterson |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Location | 36475 5 Mile Rd, Livonia, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831203116 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4301405279 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl Patterson, MD 972 Mcdonald Dr, Northville, MI 48167-1071 Ph: () - | Cheryl Patterson, MD 36475 5 Mile Rd, Livonia, MI 48154-1971 Ph: (734) 655-2022 |
News Archive
Key international experts in the bone field are to be featured speakers and session leaders at the upcoming European Congress on Osteoporosis & Osteoarthritis (IOF-ECCEO12). As the major European bone event of the year, IOF-ECCEO12 will present the latest research and clinical advances in the bone field.
Although colorectal cancer screening tests are proven to reduce colorectal cancer mortality, only about half of U.S. men and women 50 and older receive the recommended tests, according to a report in the July 2008 issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
A vaccine used to protect travelers from cholera, an infection characterized by diarrhea and severe dehydration, could also be used effectively among those living in cholera-prone (endemic) areas, according to a research study by Ira Longini and colleagues published in PLoS Medicine.
Researchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral remdesivir, its potency increases significantly, suggesting it may be a potential antiviral candidate for the treatment of COVID-19.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) is continuing with its review of the regulatory application for use of Byetta (exenatide) injection as stand-alone therapy (monotherapy) in people with type 2 diabetes who are not achieving acceptable blood sugar control.
› Verified 2 days ago
Michael Biller, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36475 5 Mile Rd, Livonia, MI 48154 Phone: 734-665-2022 | |
Eric Silvestri, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36475 5 Mile Rd, Livonia, MI 48154 Phone: 734-655-2022 | |
Jayne Kennedy, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 36475 5 Mile Rd, Livonia, MI 48154 Phone: 734-655-2202 | |
Karen Pardo, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 36475 5 Mile Rd, Livonia, MI 48154 Phone: 734-655-2022 | |
Gail Ian, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 36475 5 Mile Rd, Livonia, MI 48154 Phone: 734-655-2022 | |
Wen Jing Chung, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36475 Five Mile Rd, Livonia, MI 48154 Phone: 734-655-4800 | |
Troy Timko, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 36475 5 Mile Rd, Livonia, MI 48154 Phone: 734-655-2022 |